Search results
North Carolina clinical trial success leads to new breast cancer treatment
WXII-TV Winston-Salem· 7 hours agoDonna Huie always heard people describe a cancer diagnosis as a "punch to the gut." An extra...
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 11 hours agoFinnish biotechnology company TILT Biotherapeutics has announced results from a Phase I clinical ...
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
The Sun Chronicle· 1 day agoNS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results from the global Phase< ...
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major...
Digital Journal· 9 hours agoPhase 2, Proof-of-Concept X-NOVA Study” May 29, 2024 at 11:15 am to 1 pm ET in Salon 4 The Company’s presentations summarize clinical ...
Aprea advances cancer drug ATRN-119 in clinical trial By Investing.com
Investing.com· 2 hours agoAprea Therapeutics, Inc. (NASDAQ:APRE), a biopharmaceutical company, has announced progression in...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 13 hours agoThe trial enrolled 388 patients across 70 sites in nine countries. Patients were randomised 1:1...
...Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and...
NBC 10 - FOX 14 Monroe· 5 days agoTyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the ...
Phio Pharmaceuticals advances to next dose in cancer trial By Investing.com
Investing.com· 2 hours agoPhio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company specializing in gene silencing...
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoThe TranStar102 study (NCT04495296) investigated osemitamab in combination with Opdivo (nivolumab)...
Innovent’s psoriasis treatment picankibart meets all endpoints in Phase III trial
Clinical Trials Arena via Yahoo Finance· 12 hours agoCLEAR-1 is claimed to be the first Phase III trial in the IL-23p19 class to report more than 80% of...